MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cmi.2024.09.020

Медицинская библиотека · Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2024

Effectiveness of the enterovirus A71 vaccine on hand, foot, and mouth disease: a real-world study in China.

Liu Yuanhua, Song Yang, Liu Fengfeng, Chen Yue, Liu Yang, Shi Jin, Li Ke, Yin Yun, Liang Qingqing, Liu Na, Ming Ming, Hua Lei, Shi Qian, Xu Jiayao, Yuan Rui, Li Shuting, Zhang Lele, Zhao Yu, Wang Na, Zhang Jidan, Zhang Yanping, Chang Zhaorui, Zhang Zhijie

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

For the prevention of hand, foot, and mouth disease (HFMD), enterovirus A71 (EV-A71) vaccines have been used in China since 2016. To better inform vaccination strategies, we assess the real-world effectiveness of EV-A71 vaccination in China.

METHODS

The analysis was based on surveillance data of HFMD caused by EV-A71 in children under the age of 5 in China, along with meteorological and demographic data. The seasonal autoregressive integrated moving average model and the interrupted time series analysis were used to estimate the effectiveness of the EV-A71 vaccination on the EV-A71 HFMD incidence and to predict the counterfactual cases with no EV-A71 vaccine.

RESULTS

Between 2010 and 2018, 6 712 613 cases of HFMD caused by EV-A71 were reported in children under 5 years old in 260 Chinese cities. During 2017-2018, the EV-A71 vaccination was associated with a reduction in EV-A71 HFMD incidence, with a relative risk of 0.83 (95% CI, 0.81-0.86), and an estimated reduction of 297 946 (95% CI, 250 534-346 658) cases. However, this association varied across cities (I2 = 85.6%, p < 0.001) and the effectiveness of the EV-A71 vaccination decreased as population density increased. Higher vaccination coverage was associated with greater effectiveness of the EV-A71 vaccination and an earlier point in EV-A71 case reduction. Specifically, when the vaccination coverage exceeded ∼20%, the relative risk was rapidly reduced to below 0.71 (95% CI, 0.69-0.72).

DISCUSSION: Our study demonstrated that the EV-A71 vaccination was associated with a reduction in the incidence of EV-A71 HFMD, but the association varied with regions and was influenced by vaccination coverage and population density. To optimize EV-A71 HFMD prevention, increasing vaccination coverage (>20%) is recommended for children under 5 years old.

Для цитирования: Liu Yuanhua, Song Yang, Liu Fengfeng, Chen Yue, Liu Yang, Shi Jin, Li Ke, Yin Yun, Liang Qingqing, Liu Na, Ming Ming, Hua Lei, Shi Qian, Xu Jiayao, Yuan Rui, Li Shuting, Zhang Lele, Zhao Yu, Wang Na, Zhang Jidan, Zhang Yanping, Chang Zhaorui, Zhang Zhijie. Effectiveness of the enterovirus A71 vaccine on hand, foot, and mouth disease: a real-world study in China.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2024. DOI: 10.1016/j.cmi.2024.09.020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.